RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/citations/22074999http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/22074999http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/22074999http://www.w3.org/2000/01/rdf-schema#comment"A cross-section of black and Caucasian South Africans (N = 302) were genotyped at high resolution (class I HLA-A, -B, -C and class II HLA-DRB1). Five new class I alleles (A*30:01:02, A*30:02:02, A*68:27, B*42:06, and B*45:07) and one new confirmatory allele (A*29:11) were identified in the black population. Alleles and haplotypes showed expected differences between the black and Caucasian populations, with the black population, on average, showing a broader spectrum of allele representation (less single allele dominance). The most prevalent alleles at the four loci in the black population were A*30:01, B*58:02, C*06:02, and DRB1*13:01 and in the Caucasian population were A*02:01:01, B*07:02:01, C*07:01, and DRB1*03:01. HLA-B, and HLA-C loci showed the strongest overall linkage disequilibrium (LD) and HLA-B/HLA-C two locus haplotypes also showed the strongest LD (D'(ij)) in both population groups. Bw allotype representation was similar between the two populations; however C allotypes differed significantly (C1 higher representation in Caucasians; C2 higher representation in blacks). HLA-A Supertype family phenotypic frequencies did not differ between the two populations, but four (B08, B27, B58, and B62) HLA-B Supertype families differed significantly. However, vaccine coverage estimation came close to 100% in both population groups, with inclusion of only four Supertype families (A1, A2, B7, B58)."xsd:string
http://purl.uniprot.org/citations/22074999http://purl.org/dc/terms/identifier"doi:10.1016/j.humimm.2011.10.013"xsd:string
http://purl.uniprot.org/citations/22074999http://purl.org/dc/terms/identifier"doi:10.1016/j.humimm.2011.10.013"xsd:string
http://purl.uniprot.org/citations/22074999http://purl.uniprot.org/core/author"Tiemessen C.T."xsd:string
http://purl.uniprot.org/citations/22074999http://purl.uniprot.org/core/author"Tiemessen C.T."xsd:string
http://purl.uniprot.org/citations/22074999http://purl.uniprot.org/core/author"Colvin M."xsd:string
http://purl.uniprot.org/citations/22074999http://purl.uniprot.org/core/author"Colvin M."xsd:string
http://purl.uniprot.org/citations/22074999http://purl.uniprot.org/core/author"Gentle N.L."xsd:string
http://purl.uniprot.org/citations/22074999http://purl.uniprot.org/core/author"Gentle N.L."xsd:string
http://purl.uniprot.org/citations/22074999http://purl.uniprot.org/core/author"Gray C.M."xsd:string
http://purl.uniprot.org/citations/22074999http://purl.uniprot.org/core/author"Gray C.M."xsd:string
http://purl.uniprot.org/citations/22074999http://purl.uniprot.org/core/author"Mathebula T.Y."xsd:string
http://purl.uniprot.org/citations/22074999http://purl.uniprot.org/core/author"Mathebula T.Y."xsd:string
http://purl.uniprot.org/citations/22074999http://purl.uniprot.org/core/author"Paximadis M."xsd:string
http://purl.uniprot.org/citations/22074999http://purl.uniprot.org/core/author"Paximadis M."xsd:string
http://purl.uniprot.org/citations/22074999http://purl.uniprot.org/core/author"Puren A."xsd:string
http://purl.uniprot.org/citations/22074999http://purl.uniprot.org/core/author"Puren A."xsd:string
http://purl.uniprot.org/citations/22074999http://purl.uniprot.org/core/author"Vardas E."xsd:string
http://purl.uniprot.org/citations/22074999http://purl.uniprot.org/core/author"Vardas E."xsd:string
http://purl.uniprot.org/citations/22074999http://purl.uniprot.org/core/date"2012"xsd:gYear
http://purl.uniprot.org/citations/22074999http://purl.uniprot.org/core/date"2012"xsd:gYear
http://purl.uniprot.org/citations/22074999http://purl.uniprot.org/core/name"Hum. Immunol."xsd:string
http://purl.uniprot.org/citations/22074999http://purl.uniprot.org/core/name"Hum Immunol"xsd:string